SPARC’s Rs 250-crore rights issue to open on March 28
The proceeds of the issue will be utilised for meeting costs related to pharma research and development
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Health Ministry bans 344 fixed dose combination drugs
The ban on the drugs comes into immediate effect
Express Pharma (Vol.11, No.10) March 16-31, 2016
India's Foremost Pharma & Biotech Magazine
Signet-Meggle’s seminar on DPI held in Mumbai
The seminar provided in-depth information on DPI technology using properties of lactose powder
Essentra extends pharma packaging footprint into India
The company has recently acquired pharma assets of Kamsri Printing & Packaging in India
Pfizer stops sale of Corex after government ban
Pfizer said Corex maintains a 'well established efficacy and safety profile in India' and the 'company is exploring all available…
Drug formulations under price control rise to over 800
The process of fixing the ceiling prices could take another two months
Serialisation Seminar for CMO’s
Optel Vision, in collaboration with Conval Group and TraceLink is organising a common platform for the Indian pharma industry to…
Dr Reddy’s and TR-Pharm in agreement
TR-Pharm will manufacture the drug substance and drug product upon completion of its facility investment in Turkey
NPPA seeks to recover Rs 4,551 crore for overcharging
82 per cent of the total amount is under litigation